Skip to content

Idexx Laboratories IDXX Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

Zoetis logo
ZoetisZTS
Danaher logo
DanaherDHR
Agilent Technologies logo
Agilent TechnologiesA
Revvity logo
RevvityRVTY
Veracyte logo
VeracyteVCYT
Exagen Inc. logo
Exagen Inc.XGN

Other financials

Income statement

See full
Revenue$1.1B+14.3%
Gross profit$722.7M+15.9%
Operating income$362.6M+14.5%
Net income$278.4M+14.7%
EPS (diluted)$3.47+17.2%

Balance sheet

See full
Cash & equivalents$200.5M+22.3%
Total debt$575.5M-22.2%
Total equity$1.6B+7.5%
Total assets$3.4B+5.3%

Cash flow

See full
Operating cash flow$266.2M+11.9%
CapEx$32.0M+6.5%
Free cash flow$234.3M+12.7%

Valuation

See full
Market cap$41.53B+3.7%
Enterprise value$41.9B+3.3%
P/E37.9×-2.7×
P/S9.3×-0.6×

Profitability

See full
Gross margin62.1%+0.8pp
Operating margin31.6%+2.5pp
Net margin24.6%+1.9pp
FCF margin24.4%+2.8pp

Returns & leverage

See full
Return on equity72.9%+13.6pp
Debt / equity0.4×-0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Idexx Laboratories in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Idexx Laboratories's common stock, shares, outstanding?
Idexx Laboratories (IDXX) reported common stock, shares, outstanding of $79.24M in Q1 2026.
How has Idexx Laboratories's common stock, shares, outstanding changed year-over-year?
Idexx Laboratories's common stock, shares, outstanding decreased by 1.9% year-over-year, from $80.74M to $79.24M.
What is the long-term trend for Idexx Laboratories's common stock, shares, outstanding?
Over 5 years (2020 to 2025), Idexx Laboratories's common stock, shares, outstanding has grown at a -1.4% compound annual growth rate (CAGR), from $85.45M to $79.71M.